Tourmaline Bio Inc. (TRML)
NASDAQ: TRML
· Real-Time Price · USD
22.80
0.34 (1.51%)
At close: Aug 21, 2025, 2:22 PM
1.51% (1D)
| Bid | 21.71 |
| Market Cap | 585.67M |
| Revenue (ttm) | 40K |
| Net Income (ttm) | -88.47M |
| EPS (ttm) | -3.44 |
| PE Ratio (ttm) | -6.63 |
| Forward PE | -5.65 |
| Analyst | Buy |
| Ask | 23.26 |
| Volume | 55,706 |
| Avg. Volume (20D) | 220,369 |
| Open | 22.32 |
| Previous Close | 22.46 |
| Day's Range | 22.24 - 23.00 |
| 52-Week Range | 11.56 - 29.79 |
| Beta | 2.06 |
About TRML
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRML
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TRML stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-2.59%
TRML stock has given up its prior loss. Tourmaline...
Unlock content with
Pro Subscription
3 months ago
-2.59%
Tourmaline Bio shares are trading lower. The company announced topline results from its ongoing Phase 2 TRANQUILITY trial.
